Powdered Crosslinked Raw Materials
New technologyis used to transform polysaccharides into bio-networks, applicable to different areas of medicine for the purpose of drug delivery, to stabilize and optimize the performance of initial raw materials. These technologies make it possible to convert a complex process consisting of various transformation and purification steps of an initial substance into a powdered raw material, thereby facilitating and making this technology accessible to companies operating in specific medical sectors.
Crosslinked Hyaluronic Acid Powder
CrossYal is the first cross-linked hyaluronic acid powder specific for topical ophthalmic use, offering heat stability and resistance to degradation. CrossYal is a hyaluronic acid that remains stable, viscous and non-gelling even at high concentrations, sterilizable by 0.2-micron filtration, therefore making it suitable for the industrial production processes of ophthalmic drops.
Crosslinked Carboxymethyl Cellulose Powder
CelluCross is a cross-linked carboxymethylcellulose-based polymer of 0.2-micron filtration for concentrations up to 0.5% – 0.6%. Crosslinking enhances mucoadhesion and improves viscoelasticity. The product was designed for ophthalmic gels but can also be used in other areas of medicine, making full use of the characteristics of cellulose derivatives.
Crosslinked RNA Powder
Crosslinked RNA of cosmetic and ophthalmic grade. The cross-linking process transforms an active pharmacological principle, with universally known functions in the treatment of lesions, micro-lesions and collagen stimulation, into a viscoelastic polymer, thereby broadening its application and enabling access to the sector of medical devices.
